Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level.

Liu M, Zhu H, Yang S, Wang Z, Bai J, Xu N.

Cell Biol Int. 2013 Mar;37(3):197-202. doi: 10.1002/cbin.10039. Epub 2013 Jan 30.

PMID:
23364919
2.

Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level.

Wang Z, Liu M, Zhu H, Zhang W, He S, Hu C, Quan L, Bai J, Xu N.

Int J Oncol. 2010 Nov;37(5):1315-21.

PMID:
20878079
3.

miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.

Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA.

Nat Cell Biol. 2010 Mar;12(3):247-56. doi: 10.1038/ncb2024. Epub 2010 Feb 21.

4.

Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.

Xiong J, Du Q, Liang Z.

Oncogene. 2010 Sep 2;29(35):4980-8. doi: 10.1038/onc.2010.241. Epub 2010 Jun 21.

PMID:
20562918
5.

MiR-155 negatively regulates c-Jun expression at the post-transcriptional level in human dermal fibroblasts in vitro: implications in UVA irradiation-induced photoaging.

Song J, Liu P, Yang Z, Li L, Su H, Lu N, Peng Z.

Cell Physiol Biochem. 2012;29(3-4):331-40. doi: 10.1159/000338488. Epub 2012 Apr 3.

6.

MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.

Rothschild SI, Tschan MP, Federzoni EA, Jaggi R, Fey MF, Gugger M, Gautschi O.

Oncogene. 2012 Sep 20;31(38):4221-32. doi: 10.1038/onc.2011.578. Epub 2012 Jan 16.

PMID:
22249264
8.

Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.

Lu MH, Huang CC, Pan MR, Chen HH, Hung WC.

Clin Cancer Res. 2012 Dec 1;18(23):6416-25. doi: 10.1158/1078-0432.CCR-12-0832. Epub 2012 Oct 8.

9.

Polyamines regulate E-cadherin transcription through c-Myc modulating intestinal epithelial barrier function.

Liu L, Guo X, Rao JN, Zou T, Xiao L, Yu T, Timmons JA, Turner DJ, Wang JY.

Am J Physiol Cell Physiol. 2009 Apr;296(4):C801-10. doi: 10.1152/ajpcell.00620.2008. Epub 2009 Jan 28.

10.

miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer.

Tai MC, Kajino T, Nakatochi M, Arima C, Shimada Y, Suzuki M, Miyoshi H, Yatabe Y, Yanagisawa K, Takahashi T.

Carcinogenesis. 2015 Dec;36(12):1464-73. doi: 10.1093/carcin/bgv152. Epub 2015 Oct 18.

PMID:
26483346
11.

miR-200b mediates post-transcriptional repression of ZFHX1B.

Christoffersen NR, Silahtaroglu A, Orom UA, Kauppinen S, Lund AH.

RNA. 2007 Aug;13(8):1172-8. Epub 2007 Jun 21.

12.

Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.

Jung HM, Patel RS, Phillips BL, Wang H, Cohen DM, Reinhold WC, Chang LJ, Yang LJ, Chan EK.

Mol Biol Cell. 2013 Jun;24(11):1638-48, S1-7. doi: 10.1091/mbc.E12-12-0891. Epub 2013 Apr 3.

13.

Bromodichloromethane induces cell proliferation in different tissues of male F344 rats by suppression of E-cadherin expression via hypermethylation or transcriptional activation of c-myc and cyclin D1.

Liao J, Li XF, Zhou SC, Luo Y, Liu AL, Lu WQ.

Toxicol Lett. 2013 Nov 25;223(2):162-74. doi: 10.1016/j.toxlet.2013.08.016. Epub 2013 Aug 31.

PMID:
24001804
14.

miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements.

Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O'Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O, Becker KG, Gorospe M, Hide W, Lieberman J.

Mol Cell. 2009 Sep 11;35(5):610-25. doi: 10.1016/j.molcel.2009.08.020.

15.

MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells.

Ikemura K, Yamamoto M, Miyazaki S, Mizutani H, Iwamoto T, Okuda M.

Mol Pharmacol. 2013 Feb;83(2):399-405. doi: 10.1124/mol.112.081844. Epub 2012 Nov 19.

16.

MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.

Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Chang I, Tanaka Y, Gupta A, Dahiya R.

Carcinogenesis. 2012 Feb;33(2):294-300. doi: 10.1093/carcin/bgr286. Epub 2011 Dec 9.

17.

Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.

Chen F, Zhu HH, Zhou LF, Wu SS, Wang J, Chen Z.

Oncol Rep. 2010 May;23(5):1457-62.

PMID:
20372864
18.

E-cadherin repression contributes to c-Myc-induced epithelial cell transformation.

Cowling VH, Cole MD.

Oncogene. 2007 May 24;26(24):3582-6. Epub 2006 Dec 4.

PMID:
17146437
19.

Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.

Han M, Liu M, Wang Y, Chen X, Xu J, Sun Y, Zhao L, Qu H, Fan Y, Wu C.

PLoS One. 2012;7(6):e39520. doi: 10.1371/journal.pone.0039520. Epub 2012 Jun 25.

20.

MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.

Wei W, Hu Z, Fu H, Tie Y, Zhang H, Wu Y, Zheng X.

Oncol Rep. 2012 Aug;28(2):701-6. doi: 10.3892/or.2012.1850. Epub 2012 Jun 1.

PMID:
22664953

Supplemental Content

Support Center